Mittie Doyle's Net Worth
$0
Who is Mittie Doyle?
Mittie Doyle does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DICE Therapeutics, Inc., and Avalo Therapeutics, Inc..
SEC CIK
Mittie Doyle's CIK is 0001918845
Past Insider Trading and Trends
2022 was Mittie Doyle's most active year for acquiring shares with 1 total transactions. Mittie Doyle's most active month to acquire stocks was the month of February. 2023 was Mittie Doyle's most active year for disposing of shares, totalling 1 transactions. Mittie Doyle's most active month to dispose stocks was the month of July. 2024 saw Mittie Doyle paying a total of $0.00 for 234,000 shares, this is the most they've acquired in one year. In 2023 Mittie Doyle cashed out on 42,500 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DICE Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Avalo Therapeutics, Inc. (AVTX) Snapshot price: $7.25
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||